Back to News

People Don't Want Ketamine. They Want Their Lives Back.

David Sjöström

A person walking through a calm landscape

The drill, the hole and the shelf

There is a well-known business quote, often attributed to Theodore Levitt: ‘People don’t want to buy a quarter-inch drill. They want a quarter-inch hole.’ It reminds us that people rarely buy products for their own sake. They buy what those products enable. But the metaphor can be taken further. People do not really want the hole. They want a shelf. And they do not truly want the shelf. They want somewhere to place their books, family photographs and the objects that make a house feel like home. The shelf was never the goal—it was simply a step towards something that mattered more.

What clinical practice taught me

After many years working as a medical doctor in psychiatry and primary care, I have met thousands of people seeking help for psychological suffering. Almost nobody came asking for a specific treatment modality. They did not ask for cognitive behavioural therapy, psychodynamic therapy or ketamine. They wanted relief from depression, freedom from anxiety, to be present with their children, to return to work, to reconnect with loved ones and to recognise themselves again. That experience has profoundly shaped how I think about mental healthcare. Treatments matter, but they should never become the centre of the conversation. They are tools in service of human goals.

The danger of falling in love with the tool

Every generation of mental healthcare has embraced new methods. Psychoanalysis, antidepressants, mindfulness, digital therapeutics and now psychedelic medicine have each expanded what is possible. Yet every innovation carries the temptation to mistake the tool for the purpose. Patients are not seeking a drug, an app or even psychotherapy itself. They are seeking a life that feels worth living.

Why Nūvai exists

When we founded Nūvai, it would have been easy to define ourselves as a ketamine clinic or a psychedelic clinic. Those labels are simple but incomplete. Our mission is not to deliver a particular intervention; it is to help people recover and sustain meaningful lives. That is why we speak about precision psychotherapy. Precision psychotherapy is not another school of therapy. It is a philosophy of care that begins with the observation that every person differs in biology, psychology, life history, relationships, strengths and vulnerabilities. Treatment should adapt to the individual, not the other way around.

Our hypothesis is not that ketamine or psychedelic medicines are treatments in themselves. Rather, we believe they may, in carefully selected patients, temporarily increase the conditions under which psychotherapy becomes more effective. Reduced experiential avoidance, increased psychological flexibility, greater emotional engagement and new perspectives may allow therapeutic work that would otherwise be difficult.

Betting on the books, not the drill

This is where the shelf metaphor becomes important. At Nūvai we are not betting on psychedelic medicines because they are novel or because they generate headlines. We are betting on the possibility that, when thoughtfully integrated into precision psychotherapy, they may help more people place more books on the shelf. In other words, we are betting on greater clinically relevant efficacy, not simply greater symptom reduction. For us, success is measured by whether people rebuild relationships, return to work, recover meaning, experience greater wellbeing and sustain those gains over time. Those are the outcomes patients care about most. Those are the books on the shelf.

Why research matters

The current evidence for ketamine in treatment-resistant depression is encouraging. The evidence that ketamine-assisted psychotherapy is superior to pharmacological administration alone is still evolving. We see this not as a reason for certainty, but as a reason for research. Nūvai therefore aims to combine clinical care with longitudinal outcome monitoring and collaborative research. If psychedelic-assisted psychotherapy truly creates better long-term outcomes, we should be able to demonstrate it. If it does not, we should be willing to learn that as well.

Answers to our most common questions.

Is esketamine treatment legal in Sweden?

Yes, esketamine treatment is legal in Sweden when prescribed by a licensed physician. Esketamine has been used medically for over 50 years and is an approved medicine. At Nūvai the treatment is administered under controlled conditions by qualified medical staff, in accordance with current regional guidelines.

What does the treatment cost?

Nūvai's goal is that precision therapy, with or without treatment additions, should be accessible to everyone who needs it. Today the treatment is paid for privately, but we are working towards being able to cover all or part of it through private insurers or health insurance (within the high-cost protection scheme) in the future. The cost varies depending on the treatment plan and individual needs. A digital screening call costs SEK 2,500. Ketamine-assisted therapy starts from 33,000 kr. We also offer the option to pay in instalments via Klarna. You are welcome to contact us for a personal and free cost estimate.

How many sessions are needed?

The number of sessions depends on the type of treatment, your needs and how you respond to it. The plan is followed up and adjusted continuously together with your therapist. For ketamine-assisted precision psychotherapy the model is inspired by international protocols where ketamine is usually given as a series of six infusions over about four weeks. Psilocybin-assisted therapy takes place abroad and usually involves 1–2 dosing sessions over a week, with time for local preparation and integration. Breathwork as a treatment addition is usually provided twice a week for four weeks, either at the clinic or online. The exact scope is always tailored to your situation, your goals and your response to treatment.

Can I continue with my current medication?

In most cases you can continue with your existing medication, but this is assessed individually by our physicians who are specialists in psychiatry and anaesthesia. Some medicines may need to be adjusted ahead of treatment, and sometimes it is desirable to taper off or change them afterwards. We help you with this if you wish. At the initial consultation our physicians review your full medication list and give concrete recommendations. Never make changes to your medication without consulting your care provider.

Can I be referred by my doctor or psychologist?

Absolutely. We accept referrals from other care providers and they can contact us directly by email at info@nuvai.se. You are also welcome to apply for an assessment yourself — a referral is not a requirement to begin treatment with us. Please be careful not to write personal data in emails to us.